Cite

HARVARD Citation

    Pose, E. et al. (2022). Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis. Hepatology communications. 6 (5), pp. 1100-1112. [Online]. 
  
Back to record